PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-24.2%
5Y CAGR-51.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-24.2%/yr
vs -54.5%/yr prior
5Y CAGR
-51.8%/yr
Recent acceleration
Acceleration
+30.3pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.18 | -65.9% |
| 2024 | 0.51 | -34.3% |
| 2023 | 0.78 | +94.6% |
| 2022 | 0.40 | -93.2% |
| 2021 | 5.95 | -11.8% |
| 2020 | 6.74 | -27.1% |
| 2019 | 9.25 | -1.3% |
| 2018 | 9.37 | +18.2% |
| 2017 | 7.93 | -2.9% |
| 2016 | 8.17 | - |